Cloudpharm
Cloudpharm provides computational tools to help biomedical companies discover and develop new drugs. They build AI-driven in silico methods for drug design, drug repurposing, and predictive modeling as part of their platform and services. Category includes B2B SaaS, computational services, and consulting; typical customers are pharmaceutical R&D companies. Leveraging proprietary technology and a network of collaborators, they act as an R&D partner for companies seeking advanced methodologies. Based in Greece since 2016, they were recognized in Europe as a top provider in drug discovery and development in 2023.
Cloudpharm
Cloudpharm provides computational tools to help biomedical companies discover and develop new drugs. They build AI-driven in silico methods for drug design, drug repurposing, and predictive modeling as part of their platform and services. Category includes B2B SaaS, computational services, and consulting; typical customers are pharmaceutical R&D companies. Leveraging proprietary technology and a network of collaborators, they act as an R&D partner for companies seeking advanced methodologies. Based in Greece since 2016, they were recognized in Europe as a top provider in drug discovery and development in 2023.